When evaluating the ADC, only the semaglutide group had a significant change compared with placebo, with a reduction from 0.1910 3 mm 2 /s (95% CI 0.16, 0.23) at baseline to 0.0810 3 mm 2 /s (95% CI 0.01, 0.14) at 32 weeks ( p =0.01) (corresponding to a reduction of 63%) (Fig
Some say that it is less important for keto dieters because the diet provides many of the same benefits
Based on the significant unmet need in Alzheimers disease as well as a number of indicative data points, we felt we had a responsibility to explore semaglutides potential, despite a low likelihood of success, Martin Holst Lange, chief scientific officer at Novo Nordisk said in a press release
2022;378:e069679
Some patients taking semaglutide report trouble sleeping, possibly due to nausea, discomfort, or changes in metabolism
Persistent tiredness could indicate that your body isn't adjusting as anticipated and may necessitate adjusting your dosage or a change in treatment plan